Stay updated with breaking news from Sven Dethlefs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
TEVA earnings call for the period ending September 30, 2023.
Grant funding of $75,000 to each clinic is part of Teva’s $2 million, two-year commitment to support clinics’ innovative mental and behavioral health programs tailored to meet community...
Teva Pharmaceutical Industries Ltd. today announced changes to its leadership team. Sven Dethlefs, Executive Vice President, North America Commercial, will leave Teva on November 17, 2023, and...